# Vantix Diagnostics, Inc.: Form D filings

Vantix Diagnostics, Inc., a biotechnology company in Pelham, NH, filed 5 Form D notices with the SEC between 2012 and 2014. The latest, on February 11, 2014, reports $4.9 million sold of a $16 million offering to 52 investors.

Find out what Vantix Diagnostics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Vantix%20Diagnostics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Vantix%20Diagnostics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fvantix-diagnostics-inc-1558003)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Vantix%20Diagnostics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Vantix%20Diagnostics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fvantix-diagnostics-inc-1558003)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Hampshire](https://specstream.ai/data/form-d/state/new-hampshire): 127 rows, by operating companies, filed since November 1, 2024, $6.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-hampshire
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 70 BRIDGE ST. #8, Pelham, NH, 03076
- Phone: (603) 459-0715
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2010
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1558003

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 11, 2014 | Amendment | $16,000,000 | $4,947,000 | $11,053,000 | 52 | Jun 13, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1558003/000155800314000001/0001558003-14-000001-index.htm) |
| Jan 23, 2013 | New notice | $16,000,000 | $0 | $16,000,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1558003/000155800313000003/0001558003-13-000003-index.htm) |
| Jan 23, 2013 | New notice | $250,000 | $0 | $250,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1558003/000155800313000002/0001558003-13-000002-index.htm) |
| Oct 19, 2012 | Amendment | $1,400,000 | $1,140,000 | $260,000 | 13 | Aug 30, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1558003/000155800312000002/0001558003-12-000002-index.htm) |
| Sep 12, 2012 | New notice | $1,100,000 | $250,000 | $850,000 | 5 | Aug 30, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1558003/000155800312000001/0001558003-12-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Steve Lufkin | Executive Officer, Director, Promoter |  |
| Doug Armstrong | Director |  |
| Richard Wardle | Director |  |
| Anthony Pintsopoulos | Promoter |  |
| Richard Rappaport | Promoter |  |

[Every Form D from the week of Feb 10, 2014](https://specstream.ai/data/form-d/week/2014-02-10) · [All recent filings in New Hampshire](https://specstream.ai/data/form-d/state/new-hampshire) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Vantix Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).